Sign up today and learn more about Synthorx Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Synthorx Stock
Synthorx is a biotechnology company using ground-breaking synthetic biology starting with our novel DNA base pair to discover and develop new protein therapeutics. The company uses new building blocks to create proteins that impart specificity not possible with native proteins. The result is treatments with improved efficacy, better safety, and better convenience for patients. Utilizing proprietary engineered organisms we have the ability to manufacture these improved proteins with high fidelity and the required yield for drug discovery and development. This unique platform expands the chemical and structural repertoire of protein therapeutics and uncovers new ways to modulate pharmacological properties of biologics, not possible with other technologies.
Chief Scientific Officer
President and CEO
Founder and Director
Floyd E. Romesberg